BB-3644 oral combined matrix metalloproteinase and tumor necrosis factor (TNF) inhibitor: Phase I Update

British Biotech plc

Read the full 37 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE